You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

carfilzomib

Showing 76 - 100 of 159
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in United States (Magrolimab, Daratumumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Magrolimab
  • +5 more
  • Tucson, Arizona
  • +8 more
Jul 28, 2022

Multiple Myeloma Trial in Spain (REGN5458, Daratumumab, Carfilzomib)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +8 more
Nov 30, 2022

Amyloidosis Trial in United Kingdom (Carfilzomib, Thalidomide, Dexamethasone)

Completed
Has Results
  • Amyloidosis
  • Carfilzomib
  • +2 more
  • Plymouth, Devon, United Kingdom
  • +13 more
Mar 18, 2021

Multiple Myeloma, New Diagnosis Tumor Trial in Italy (Carfilzomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • New Diagnosis Tumor
  • Carfilzomib
  • +2 more
  • Alessandria, Italy
  • +41 more
Mar 24, 2022

Smoldering Multiple Myeloma Trial in Spain (carfilzomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • carfilzomib
  • +3 more
  • Barcelona, Spain
  • +15 more
Feb 15, 2021

Multiple Myeloma Trial in United States (Carfilzomib, Dexamethasone, Prednisone)

Unknown status
  • Multiple Myeloma
  • Carfilzomib
  • +5 more
  • Encinitas, California
  • +6 more
Aug 12, 2020

ISS Stage III Plasma Cell Myeloma, Plasma Cell Myeloma Trial in Rochester (procedure, drug, biological)

Not yet recruiting
  • ISS Stage III Plasma Cell Myeloma
  • Plasma Cell Myeloma
  • Bone Marrow Aspiration and Biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 9, 2022

Newly Diagnosed Multiple Myeloma Trial in Austria, Germany (Elotuzumab, Carfilzomib, Lenalidomide)

Active, not recruiting
  • Newly Diagnosed Multiple Myeloma
  • Krems, Lower Austria, Austria
  • +55 more
Jan 4, 2022

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Carfilzomib)

Completed
Has Results
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Boca Raton, Florida
  • +112 more
Sep 9, 2022

Transplants and Implants Trial in Cincinnati (Carfilzomib, Rituximab)

Unknown status
  • Transplants and Implants
  • Cincinnati, Ohio
  • +1 more
Jun 29, 2020

Multiple Myeloma Trial (Pembrolizumab, Lenalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Pembrolizumab
  • +3 more
  • (no location specified)
Mar 12, 2021

Multiple Myeloma Trial in Worldwide (Daratumumab, Carfilzomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Nantes Cedex 1, France
  • +19 more
Aug 11, 2022

DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Jacksonville,

Completed
Has Results
  • DS Stage I Plasma Cell Myeloma
  • +3 more
  • Autologous Bone Marrow Transplantation
  • +4 more
  • Jacksonville, Florida
  • +1 more
Aug 18, 2020

Relapsed or Refractory Multiple Myeloma Trial in United States (Dexamethasone, Carfilzomib)

Terminated
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • Palm Springs, California
  • +30 more
Dec 14, 2020

Kidney Cancer Trial in Houston (Carfilzomib)

Completed
Has Results
  • Kidney Cancer
  • Carfilzomib
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 21, 2020

Relapsed and/or Refractory Multiple Myeloma Trial in Japan (Ixazomib, Bortezomib, Carfilzomib)

Completed
Has Results
  • Relapsed and/or Refractory Multiple Myeloma
  • Kamogawa, Chiba, Japan
  • +22 more
Jul 27, 2022

Multiple Myeloma Trial in France (Carfilzomib, Daratumumab, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib
  • +3 more
  • Nantes, Pays De La Loire, France
  • +11 more
Apr 27, 2021

Multiple Myeloma Trial in France (Carfilzomib)

Unknown status
  • Multiple Myeloma
  • Carfilzomib
  • Avignon, France
  • +32 more
Aug 26, 2020

Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Carfilzomib
  • +2 more
  • Bakersfield, California
  • +58 more
Oct 15, 2020

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Teclistamab, Pomalidomide, Bortezomib)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Berkeley, California
  • +188 more
Jan 27, 2023

Multiple Myeloma Trial in Worldwide (Lemzoparlimab, Dexamethasone, Carfilzomib)

Terminated
  • Multiple Myeloma
  • Lemzoparlimab
  • +4 more
  • Tucson, Arizona
  • +58 more
Jul 6, 2022

Marginal Zone Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Waldenstrom Macroglobulinemia Trial in Seattle (drug, other,

Terminated
Has Results
  • Marginal Zone Lymphoma
  • +5 more
  • Carfilzomib
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 8, 2020

Lymphoma Trial in Houston (Carfilzomib, Lenalidomide, Rituximab)

Terminated
  • Lymphoma
  • Carfilzomib
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 18, 2019

Newly Diagnosed Multiple Myeloma Trial in Spain (Lenalidomide., Carfilzomib, Bortezomib)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • A Coruña, Spain
  • +64 more
Mar 12, 2021

Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

Recruiting
  • Lymphoma
  • +3 more
  • Los Angeles, California
  • +36 more
Jan 23, 2023